Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2-chloro-phenyl)-(2-(5-pyridin-4-yl-1-(3,5-bistrifluoromethyl-benzyl)-1h-(1,2,3)triazol-4-yl)pyridin-3-yl)methanone
2. Ly686017
1. 622370-35-8
2. Ly686017
3. Vly-686
4. Ly-686017
5. Ny0coc51fi
6. (2-(1-(3,5-bis(trifluoromethyl)benzyl)-5-(pyridin-4-yl)-1h-1,2,3-triazol-4-yl)pyridin-3-yl)(2-chlorophenyl)methanone
7. [2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanone
8. Methanone, (2-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-(4-pyridinyl)-1h-1,2,3-triazol-4-yl)-3-pyridinyl)(2-chlorophenyl)-
9. Unii-ny0coc51fi
10. Tradipitant [usan:inn]
11. Tradipitant [usan]
12. Tradipitant(vly-686)
13. Tradipitant [inn]
14. Tradipitant (usan/inn)
15. Tradipitant [who-dd]
16. Gtpl9278
17. Schembl2898629
18. Vly686
19. Chembl3544984
20. Vly 686
21. Dtxsid801045805
22. Bcp30446
23. Mfcd28127604
24. Zinc43194077
25. Cs-8056
26. Db12580
27. Sb18893
28. Ac-36943
29. As-35293
30. Da-31788
31. Hy-16732
32. Ly 686017
33. Ft-0703806
34. A16918
35. D11728
36. A915947
37. Q1798493
38. Ly686017; Ly 686017; Ly686017; Vly 686; Vly686; Vly686
39. (2-(1-(3,5-bis(trifluoromethyl)benzyl)-5-pyridin-4-yl-1h-1,2,3-triazol-4-yl)pyridin-3-yl)(2-chlorophenyl)methanone
40. {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone
41. {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl ]-pyridin-3-yl}-(2-chlorophenyl)-methanone
42. {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
| Molecular Weight | 587.9 g/mol |
|---|---|
| Molecular Formula | C28H16ClF6N5O |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 6 |
| Exact Mass | 587.0947568 g/mol |
| Monoisotopic Mass | 587.0947568 g/mol |
| Topological Polar Surface Area | 73.6 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 865 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tradipitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tradipitant, including repackagers and relabelers. The FDA regulates Tradipitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tradipitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tradipitant supplier is an individual or a company that provides Tradipitant active pharmaceutical ingredient (API) or Tradipitant finished formulations upon request. The Tradipitant suppliers may include Tradipitant API manufacturers, exporters, distributors and traders.
Tradipitant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tradipitant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tradipitant GMP manufacturer or Tradipitant GMP API supplier for your needs.
A Tradipitant CoA (Certificate of Analysis) is a formal document that attests to Tradipitant's compliance with Tradipitant specifications and serves as a tool for batch-level quality control.
Tradipitant CoA mostly includes findings from lab analyses of a specific batch. For each Tradipitant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tradipitant may be tested according to a variety of international standards, such as European Pharmacopoeia (Tradipitant EP), Tradipitant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tradipitant USP).
LOOKING FOR A SUPPLIER?
